Subscribe To
BETRF / BetterLife Pharma says LSD analog BETR-001 promotes structural neural plasticity in preclinical model
Content Topics
Betterlife
Pharma
Says
Analog
Betr
001
Promotes
Structural
Betr 001
Neural
Plasticity
Preclinical
Stock
BETRF
BETRF News
By GlobeNewsWire
April 25, 2023
BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BE more_horizontal
By Proactive Investors
March 29, 2023
BetterLife Pharma says BETR-001 drug candidate featured in Drug Discovery & Development article
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an article titled “Non-hallucinogenic LSD derivative reduces depression symptoms in more_horizontal
By Proactive Investors
March 14, 2023
BetterLife Pharma closes $1.5M private placement
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced the closing of a brokered private placement worth $1.5 million. The company is offering more_horizontal
By Proactive Investors
March 9, 2023
Betterlife Pharma's reports positive study findings for lead candidate BETR-001
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) revealed promising findings from a study on its lead candidate BETR-001 (2-bromo-LSD), a non-hallucinoge more_horizontal
By Proactive Investors
March 8, 2023
BetterLife Pharma unveils plans for a private placement offering of units
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced plans for a private placement offering of units, comprising of one common share and one co more_horizontal
By Proactive Investors
January 26, 2023
BetterLife Pharma hires strategic advisory services firm to support development toward clinical trials of its psychedelic compounds
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) announced that it has engaged Bloom Burton Securities Inc for strategic advisory services to support its more_horizontal
By Proactive Investors
December 7, 2022
BetterLife Pharma closes private placement with help from Negev Capital to fuel clinical programs
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) announced that it has closed a financing designed to advance its clinical and preclinical studies. The n more_horizontal
By Proactive Investors
December 2, 2022
BetterLife to present BETR-001 preclinical data at the American College of Neuropsychopharmacology meeting in Phoenix
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) said that one of its scientific collaborators, Dr Argel Aguilar-Valles from Carleton University's Depart more_horizontal